tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aligos Therapeutics announces first subject dosed in Phase 2 B-SUPREME study
PremiumThe FlyAligos Therapeutics announces first subject dosed in Phase 2 B-SUPREME study
2M ago
Aligos Therapeutics Reports Q2 2025 Progress and Results
Premium
Company Announcements
Aligos Therapeutics Reports Q2 2025 Progress and Results
2M ago
Aligos Therapeutics reports Q2 EPS ($1.53), consensus ($2.54)
Premium
The Fly
Aligos Therapeutics reports Q2 EPS ($1.53), consensus ($2.54)
2M ago
Aligos Therapeutics appoints Laura Kavanaugh as VP, head of legal
PremiumThe FlyAligos Therapeutics appoints Laura Kavanaugh as VP, head of legal
4M ago
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
Premium
The Fly
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
4M ago
Aligos Therapeutics presents data at EASL Congress 2025
Premium
The Fly
Aligos Therapeutics presents data at EASL Congress 2025
5M ago
Promising Clinical Data and Strategic Milestones Drive Buy Rating for Aligos Therapeutics
PremiumRatingsPromising Clinical Data and Strategic Milestones Drive Buy Rating for Aligos Therapeutics
6M ago
Aligos Therapeutics files to sell 6.25M shares of common stock for holders
Premium
The Fly
Aligos Therapeutics files to sell 6.25M shares of common stock for holders
6M ago
Aligos Therapeutics presents positive data at APASL2025
Premium
The Fly
Aligos Therapeutics presents positive data at APASL2025
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100